Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

More tachykinin NK1 antagonists reported by Sandoz

Aug. 23, 1996

Coagulation factor X inhibitors described by Yamanouchi

Aug. 16, 1996

Beta3 agonists reported by Dainippon

Aug. 16, 1996

Sanofi describes fibrinogen antagonists

Aug. 16, 1996

Fibrinogen antagonists claimed by Toyama

Aug. 16, 1996

SKB reports fibrinogen antagonists

Aug. 16, 1996

Corvas discloses thrombin inhibitors

Aug. 16, 1996

Kanebo reports Na+/H+ exchange inhibitors

Aug. 16, 1996

Antihypertensive quinazoline derivatives described by Nippon Chemiphar

Aug. 16, 1996

American Cyanamid claims vasopressin antagonists

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.